Amylyx Pharmaceuticals (AMLX) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.75
-1.02
-0.29
0.44

Details

Expected EPS
-0.004
Actual EPS
-1.75
Surprise EPS
-1.75
Surprise Percent
+43,650%

Description

Amylyx Pharmaceuticals (AMLX) has reported earnings of -1.75 per share for Q2 2024.

0 Comments

Share your thoughts